TP53
Most commonly mutated gene in cancer. Restored function via Gendicine (approved in China) for head and neck cancer.
No Treatments found for this biomarker.
Most commonly mutated gene in cancer. Restored function via Gendicine (approved in China) for head and neck cancer.
No Treatments found for this biomarker.